☰

Carrie D. House, Ph.D. - Publications

Affiliations: 
2011 Biomedical Sciences The George Washington University, Washington, DC, United States 
Area:
Molecular Biology, Oncology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Waters JA, Robinson M, Lujano-Olazaba O, Lucht C, Gilbert SF, House CD. Omental preadipocytes stimulate matrix remodeling and IGF signaling to support ovarian cancer metastasis. Cancer Research. PMID 38635891 DOI: 10.1158/0008-5472.CAN-23-2613  0.473
2023 Harrington BS, Kamdar R, Ning F, Korrapati S, Caminear MW, Hernandez LF, Butcher D, Edmondson EF, Traficante N, Hendley J, Gough M, Rogers R, Lourie R, Shetty J, Tran B, ... ... House CD, et al. UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer. Journal of Experimental & Clinical Cancer Research : Cr. 42: 270. PMID 37858159 DOI: 10.1186/s13046-023-02820-z  0.382
2022 Holmberg R, Robinson M, Gilbert SF, Lujano-Olazaba O, Waters JA, Kogan E, Velasquez CLR, Stevenson D, Cruz LS, Alexander LJ, Lara J, Mu EM, Camillo JR, Bitler BG, Huxford T, ... House CD, et al. TWEAK-Fn14-RelB signaling cascade promotes stem cell-like features that contribute to post-chemotherapy ovarian cancer relapse. Molecular Cancer Research : McR. PMID 36214671 DOI: 10.1158/1541-7786.MCR-22-0486  0.497
2021 Robinson M, Gilbert SF, Waters JA, Lujano-Olazaba O, Lara J, Alexander LJ, Green SE, Burkeen GA, Patrus O, Sarwar Z, Holmberg R, Wang C, House CD. Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells. Cancers. 13. PMID 33445692 DOI: 10.3390/cancers13020262  0.343
2018 House CD, Grajales V, Ozaki M, Jordan E, Wubneh H, Kimble DC, James JM, Kim MK, Annunziata CM. IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts. Bmc Cancer. 18: 595. PMID 29801480 DOI: 10.1186/S12885-018-4507-2  0.483
2018 House CD, Grajales V, Ozaki M, Jordan E, Wubneh H, Kimble D, Kim M, Annunziata CM. Abstract 5470: IKK-epsilon supports anchorage independent growth via alternative NF-kB signaling in triple-negative breast cancer Cancer Research. 78: 5470-5470. DOI: 10.1158/1538-7445.Am2018-5470  0.537
2018 Ozaki MK, House CD, Mazan-Mamczarz K, Lal-Nag M, Thomas C, Annunziata CM. Abstract 167: Targeting the NF-kappaB pathway with bardoxolone methyl to inhibit ovarian cancer spheroid formation Cancer Research. 78: 167-167. DOI: 10.1158/1538-7445.Am2018-167  0.518
2017 House CD, Jordan E, Hernandez L, Ozaki M, James JM, Kim M, Kruhlak MJ, Batchelor E, Elloumi F, Cam MC, Annunziata CM. NF-kB promotes ovarian tumorigenesis via classical pathways supporting proliferative cancer cells and alternative pathways supporting ALDH+ cancer stem-like cells. Cancer Research. PMID 29074539 DOI: 10.1158/0008-5472.Can-17-0366  0.598
2017 Pongas G, Kim MK, Min DJ, House CD, Jordan E, Caplen N, Chakka S, Ohiri J, Kruhlak MJ, Annunziata CM. BRD4 facilitates DNA damage response and represses CBX5/Heterochromatin protein 1 (HP1). Oncotarget. 8: 51402-51415. PMID 28881656 DOI: 10.18632/Oncotarget.17572  0.382
2017 House CD, Jordan EA, Annunziata CM. Abstract AP13: NF-KAPPAB CLASSICAL VERSUS ALTERNATIVE PATHWAYS SUPPORT DISTINCT POPULATIONS OF OVARIAN CANCER TUMOR-INITIATING CELLS Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Ovcasymp16-Ap13  0.565
2017 House CD, Annunziata CM. Abstract 1910: NF-kappaB classical versus alternative pathways support distinct populations of ovarian cancer tumor-initiating cells Cancer Research. 77: 1910-1910. DOI: 10.1158/1538-7445.Am2017-1910  0.487
2017 Ozaki MK, House CD, Annunziata CM. Abstract 112: Identifying drugs that target ovarian cancer tumor initiating cells Cancer Research. 77: 112-112. DOI: 10.1158/1538-7445.Am2017-112  0.447
2016 Kim MK, Caplen N, Chakka S, Hernandez L, House C, Pongas G, Jordan E, Annunziata CM. Identification of therapeutic targets applicable to clinical strategies in ovarian cancer. Bmc Cancer. 16: 678. PMID 27558154 DOI: 10.1186/S12885-016-2675-5  0.451
2016 Hernandez L, Kim MK, Lyle LT, Bunch KP, House CD, Ning F, Noonan AM, Annunziata CM. Characterization of ovarian cancer cell lines as in vivo models for preclinical studies. Gynecologic Oncology. PMID 27235858 DOI: 10.1016/J.Ygyno.2016.05.028  0.449
2016 House CD, Annunziata CM. Abstract A72: Dissecting the role of NF-kappaB signaling in ovarian cancer tumor-initiating cells. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A72  0.557
2015 House CD, Wang BD, Ceniccola K, Williams R, Simaan M, Olender J, Patel V, Baptista-Hon DT, Annunziata CM, Silvio Gutkind J, Hales TG, Lee NH. Voltage-gated Na(+) Channel Activity Increases Colon Cancer Transcriptional Activity and Invasion Via Persistent MAPK Signaling. Scientific Reports. 5: 11541. PMID 26096612 DOI: 10.1038/Srep11541  0.641
2015 House CD, Hernandez L, Annunziata CM. In vitro enrichment of ovarian cancer tumor-initiating cells. Journal of Visualized Experiments : Jove. PMID 25742116 DOI: 10.3791/52446  0.482
2015 House C, Grajales V, Wubneh H, Kimble D, Kim M, Annunziata C. Abstract 1955: IKKε maintains MEK activation and suppresses non-canonical NF-κB signaling in triple-negative breast cancer Cancer Research. 75: 1955-1955. DOI: 10.1158/1538-7445.Am2015-1955  0.523
2014 House CD, Hernandez L, Annunziata CM. Recent technological advances in using mouse models to study ovarian cancer. Frontiers in Oncology. 4: 26. PMID 24592355 DOI: 10.3389/Fonc.2014.00026  0.442
2012 Ceniccola KE, House CD, Bateman RJ, Nguyen A, Obias V, Ceryak SM, Mendelowitz D, Lee NH. Abstract 927: The ligand-gated Cl- channel GABA inhibits colon cancer invasion following activation by pharmacological treatments Cancer Research. 72: 927-927. DOI: 10.1158/1538-7445.Am2012-927  0.491
2011 House CD, Samaan M, Irby RB, Lee NH. Abstract 1418: Voltage-gated Na+ channel activation leads to increased invasion potential through persistent MAPK signaling involving PKA, Src, and Rap1 Cancer Research. 71: 1418-1418. DOI: 10.1158/1538-7445.Am2011-1418  0.651
2010 House CD, Vaske CJ, Schwartz AM, Obias V, Frank B, Luu T, Sarvazyan N, Irby R, Strausberg RL, Hales TG, Stuart JM, Lee NH. Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Research. 70: 6957-67. PMID 20651255 DOI: 10.1158/0008-5472.Can-10-1169  0.67
2010 Zhang JH, Panicker LM, Seigneur EM, Lin L, House CD, Morgan W, Chen WC, Mehta H, Haj-Ali M, Yu ZX, Simonds WF. Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73. Cell Death and Differentiation. 17: 1551-65. PMID 20339377 DOI: 10.1038/Cdd.2010.32  0.442
2010 House C, Vaske C, Schwartz A, Obias V, Sarvazyan N, Hales T, Stuart J, Lee N. Abstract 5292: Role of voltage-gated Na+ channels in the metastatic potential of colon cancer cells Cancer Research. 70: 5292-5292. DOI: 10.1158/1538-7445.Am10-5292  0.673
2009 Tapocik JD, Letwin N, Mayo CL, Frank B, Luu T, Achinike O, House C, Williams R, Elmer GI, Lee NH. Identification of candidate genes and gene networks specifically associated with analgesic tolerance to morphine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 5295-307. PMID 19386926 DOI: 10.1523/Jneurosci.4020-08.2009  0.302
2009 Vaske CJ, House C, Luu T, Frank B, Yeang CH, Lee NH, Stuart JM. A factor graph nested effects model to identify networks from genetic perturbations. Plos Computational Biology. 5: e1000274. PMID 19180177 DOI: 10.1371/Journal.Pcbi.1000274  0.457
Show low-probability matches.